The EFMC confers every two years, on the occasion of the EFMC-ISMC Symposium, three awards including the W.Th.Nauta Award on Pharmacochemistry, established by the Dutch Foundation "Stichting Prof. Dr.W.Th. Nauta Fonds", the UCB Award for Excellence in Medicinal Chemistry, established by UCB S.A. and the Prous Award in New Technologies in Drug Discovery, established by Prous Institute for Biomedical Research.All 3 awards consist of a diploma, € 7.500 and an invitation for a lecture by the Award recipient at the upcoming EFMC-ISMC International Symposium on Medicinal Chemistry.
Prof. Philip Portoghese, Department of Medicinal Chemistry, University of Minnesota, USA
Winner of the 2006 Nauta Award for Pharmacochemistry
Professor Portoghese receives this award for his many contributions to the field of GPCR science which have led to greater understanding of the way in which these receptors function. He is also recognised for his huge contribution to the scientific community as editor-in-chief of The Journal of Medicinal Chemistry.
Dr Bernd Riedl, Director at BayerHealthCare AG, Leverkusen, Germany
Dr. Riedl receives this award for his outstanding scientific work leading to the discovery of the raf-kinase inhibitor Sorafenib (Bay-43-9006, Nexavar), the first example of the discovery of a new medicine which combines classical rationale drug discovery approach with the use of new technologies.
Prof. Dario Neri, Swiss Federal Institute of Technology (ETH) Zürich, Switzerland
Professor Neri receives this award for his pioneering work establishing synthetic antibody libraries obtained employing phage display technology. Although this technology is still in its early stages, it holds significant potential for the discovery of new LMW binders to variety of protein targets.
The Awards are conferred on the occasion of the XIXth EFMC International Symposium on Medicinal Chemistry on the 29. of August at 5 p.m. during the opening ceremony
Follow us on Twitter
Follow us on LinkedIn